An investigation was undertaken of the extent of genetic variation occurring within infectious bronchitis virus (IBV) vaccine strains following vaccination of day-old broiler chicks. Chicks were divided into seven groups, with two groups receiving single Massachusetts (Mass) vaccinations and the other four were inoculated with combinations of different IBV serotypes; Mass, 793B, D274, and Arkansas (Ark). The remaining group was maintained as an unvaccinated control. Following vaccination, swabs and tissues collected at intervals were pooled and RNA was extracted for detection of IBV by reverse transcription polymerase chain reaction (RT PCR). Positive amplicons were sequenced for the part-S1 gene and compared to the original vaccine strain sequences. Single nucleotide polymorphisms (SNPs), amino acid variations and hydrophobicity changes were identified and recorded for each sampling point. A total of 106 SNPs were detected within 28 isolates. The average SNP counts of swab isolates were greater than those found in tissue samples. This translated into 64 amino acid changes, however only six resulted in a change to the hydrophobicity properties. All hydrophobic alterations occurred within swab isolates and the majority were recovered at 3 days post vaccination suggesting such changes to be detrimental to early virus survival. Nucleotide deletions were seen only in the group given the combination of Mass and Ark. Of the 16 sequenced samples in this group, 13 contained the same AAT deletion at position 1033 1035 in the Ark strains. Findings presented in this study demonstrate alteration in the S1 nucleotide sequence following co-administration of live IBV vaccines.
INTRODUCTION
Infectious bronchitis virus (IBV) is a positive sense single stranded RNA virus and a member of the Coronaviridae family (Gonzalez et al., 2003; Cavanagh, 2005) . The complete IBV genome is around 27.61kb (Cavanagh, 2005 ) with a GC content of 37.9%. There are a total of ten open reading frames (ORFs) that encode ten proteins, four of which are main structural proteins. These are the spike (S) glycoprotein, the membrane (M) glycoprotein, the nucleocapsid (N) protein and the small envelope (E) protein (Sutou et al., 1988;  Ammayappan & Vakharia, 2009).
It has been previously documented that new IBV genotypes can arise as a result of genetic alterations (Zhang et al., 2010; Han et al., 2011) . This is in part due to the highly variable S1 protein, a 1.7kb subunit of the S glycoprotein (Cavanagh et al., 1992) . S1 is important for attachment of the virus to host cell receptors and induces virus neutralizing and haemagglutination inhibition antibodies (Cavanagh et al., 1988; Ignjatovic & Galli, 1994;  Cavanagh & Gelb, 2008) .
Changes in nucleotide sequences, such as point mutations and insertions or deletions (indels), may have a downstream effect on the protein structure and functional consequences (Cavanagh, et al., 1992; Studer et al., 2013) . However it seems that with S1
variations, the majority of the remaining virus genome remains unchanged (Cavanagh, et al., 1992) . This has led to suggestions that the currently available vaccines may still offer partial protection against challenge from particular variant strains (Cook et al., 1999) . Under experimental conditions, the extent of genomic variation within the Arkansas (Ark) vaccine strain has been previously investigated in SPF chicks (van Santen & Toro, 2008) . Likewise, since its emergence in the 1990s (Gough et al., 1992) , 793B has been reported in most poultry producing countries leading to the widespread use of homologous live vaccines (e.g. 4/91, CR88, 1/96) (Jones, 2010) .
Nucleotide variation may affect the antigenic properties of an infecting field strain (Cavanagh, et al., 1992) , and this could potentially circumvent the protection conferred by existing vaccines. Furthermore, should a host be immunosuppressed and have a reduced ability to clear an IBV infection, virulent strains can establish within flocks with greater ease (Winterfield et al., 1978; Pejkovski et al., 1979) . We report the genomic variations occurring in seven IBV strains from four serotypes following simultaneous in vivo inoculation in IBV maternal-antibody positive commercial dayold chicks (Awad, et al., 2016) . Swabs and tissues collected at intervals from groups of chicks that were single or dual vaccinated, were subjected to IBV RT-PCR. Positive samples were sequenced and analysed for single nucleotide polymorphisms (SNPs), amino acid changes and hydrophobicity alterations.
MATERIALS AND METHODS
Chicks and ethical statement. Day-old commercial broiler chicks with maternally-derived IBV antibodies (MDA) were obtained from a commercial hatchery. Chicks were kept in an isolation unit (University of Liverpool) throughout the experiment and reared on deep litter with water and feed provided ad libitum. All experimental procedures were undertaken after approval of the University of Liverpool ethical review committee and according to the UK legislation on the use of animals for experiments.
IBV vaccines. Seven commercially available live IBV vaccine viruses were reconstituted in sterile distilled water and used either singly or in combination. For this study, the Mass vaccines are referred to as Mass 1 and Mass 2 , and the 793B vaccines are referred to as 793B 1 and 793B 2 . These monovalent vaccines were produced by different manufacturers.
Mixtures of Mass 1 +793B 1 and of Mass 2 +793B 2 were prepared as previously described (Awad, et al., 2016) . In addition, commercially combined live vaccines of Mass 1 +D274 and Mass 3 +Ark were also used (Awad, et al., 2016) . Vaccine titres (EID 50 /chick) were as follows: Mass 1 (log 10 4.0), Mass 2 (log 10 4.1), 793B 1 (log 10 4.75), 793B 2 (log 10 4.4 , Mass 1 +D274 (log 10 4.3 3 ) and Mass 3 +Ark (log 10 4.0). All vaccines were prepared prior to administration to provide the dosage per chick as recommended by the manufacturers.
Experimental design. Protocols were as previously described (Awad, et al., 2016) . Briefly, two hundred and ten day-old chicks were randomly divided into seven groups and kept in . Reaction products were visualised on a 1.5% agarose gel using electrophoresis.
Positive amplicons were purified using 0.15 µl Exonuclease 1 (EXO) and 0.99 µl shrimp alkaline phosphatase (SAP) (Affymetrix Ltd, UK) at 37 o C for 30 min, then at 80 o C for 10 min to remove extraneous material. Purified products were sent for commercial sequencing (Source BioScience, Nottingham, UK) using the positive sense (SX3+) primer for analysis of the partial S1 gene.
All IBV vaccine strains used during the study were extracted, amplified and sequenced using the above methodology to allow for comparison of redetected strains to the original vaccination strain. Our RT-PCR assay detection limits of the vaccines used in this study ranged from log 10 1.4 TCID 50 /ml to log 10 2.75 TCID 50 /ml.
Nucleotide comparison of partial S1 gene sequences within detected vaccine strains.
Sequence data was initially analysed in ChromasPRO v1.7.3 (http://technelysium.com.au/) and BLAST searches were conducted to confirm isolate identification. Alignments were carried out in MEGA6 (Tamura et al., 2013) , using Clustal W (Thompson et al., 1994) .
Retrieved IBV sequences were identified by comparison against the original vaccine sequence and BLAST (National Centre of Biotechnology Information).
Single nucleotide polymorphism (SNP) and indel detection was carried out in MEGA6 following alignment to sequenced vaccine strains. SNPs were defined as a nucleotide variation when compared to the original vaccine strain which did not alter the sequence length. SNPs were characterised as non-synonymous (ns) if they led to an amino acid change and synonymous (if they led to no amino acid changes. Indels were defined as the insertion or deletion of a nucleotide that altered the sequence length. The ds/dns ratio was calculated for each group using the Nei-Gojobori method (Nei & Kumar, 2000) , where <1.0 indicates the recovered strains to be under positive selective pressure (Fitch et al., 1991) .
Positive selection was considered significant at p<0.05. Translated amino acid variations were also identified and variations that resulted in a change in hydrophobicity were noted according to the Kyte and Doolittle scale (Kyte & Doolittle, 1982) .
RESULTS
RNA from a total of 138 isolates was extracted from tissue samples (n=74) and swabs (n=64). Following RT-PCR, interpretable sequence data for the partial S1 gene was obtained for 118 (85.51%) of them. Results from BLAST searches confirmed strain identity as the same strains as were used for initial vaccination of the birds, with homology ranging from 89% to 100% (Table 1) . IBV strains were recovered from a greater percentage of swab samples compared to the tissue samples at each of the sampling points ( Figure 1 ).
Tissues. The single Mass1 vaccine strain was detected at later stages (10 dpv onwards) and persisted in both the caecal tonsil and kidney up to 25 dpv. However, when the combined Mass 1 +793B 1 vaccine was given (Group 4), Mass 1 was only recovered in the trachea on one occasion (10 dpv), whereas the 793B-type strain had distribution within all tissues. For Group 3 (Mass 1 +D274), Mass 1 was only detected in the trachea and caecal tonsils from 10 dpv. The D274-type strain was not detected at any time point. For the single Mass 2 vaccination, the vaccine strain was detected at 3 dpv in the duodenum and from 10 dpv in other tissues. In Group 5, where Mass 2 was given in combination with 793B 2 , it was not detected at any time points. In contrast, the 793B vaccine strain was detected from 3 to 18 dpv in all sampled tissues, and only in the trachea at 25 dpv. For Group 6 (Mass 3 +Ark), the Mass 3 strain was only detected on one occasion at 3 dpv in the trachea, however the Arktype strain persisted for longer in the caecal tonsils and kidney (up to 14 dpv) ( Table 1) .
Swabs. In the single Mass 1 group, the OP swabs were positive from 3 to 18 dpv compared to 6-14 dpv for the CL swabs. In the Mass 1 +793B 1 group, Mass 1 was only detected up to 10 dpv in the OP and CL swabs and thereafter only 793B was detected. In the Mass 1 +D274 group, only Mass 1 was detected in the OP and CL swabs, with D274 not being detected at any sampling time. For the single Mass 2 inoculated birds, other than 24 dpv for OP and 3 dpv for CL, the strain was consistently detected in both swab locations. In contrast, when Mass 2 was simultaneously given alongside 793B 2 , it was only detected at 3 dpv in the OP and CL swabs, and at the remaining sampling intervals only 793B 2 was detected. In the birds where Mass 3 +Ark was given, the Mass 3 strain was only detected at 3 dpv in the OP swab and Ark was detected from OP and CL from 10 and 14 dpv respectively (Table 1) .
SNP identification.
Following alignment to the relevant vaccine sequence, SNPs were identified within the 118 isolates. A total of 28 isolates (tissue = 15 and swabs = 13) contained at least one SNP present within their sequence, with the swab isolates having a greater number of SNPs overall (83 compared to 23 in the tissue isolates) ( Table 2 ).
Average SNP counts were higher in the swab isolates with 1.57 per sample compared to 0.35 per sample in the tissue.
SNP and amino acid variation analysis.
We identified 114 nucleotide variations from the 36 isolates containing at least one SNP (3.12 per sample). This translated into a total of 64 amino acid changes (1.78 per sample) from the original vaccine strain. The majority of amino acid changes (n=56) occurred in Groups 5 and 6, with the remaining eight in Groups 1 and 2 (three and five samples respectively). Groups 3 contained only a single SNP and no amino acid variations. Group 4 contained no SNPs when compared to the original inoculated strain.
Virus strains recovered from cloacal and kidney tissue demonstrated a greater number of non-synonymous SNPs (7 and 5 respectively) when compared to trachea and duodenum tissue isolates (one in both). From the same tissue samples, a greater number of SNPs were witnessed after 10 dpv. Interestingly, within Group 6 (Ark-type), all SNPs were non-synonymous (n=10) and at the same position (976; thymine to adenine) (Figure 2 ). This resulted in an amino acid change of tyrosine to asparagine; however this did not cause a change in hydrophobicity.
On average, OP swab samples contained a lower total number of SNPs than the CL swabs (37 compared to 46). However, OP samples had a ds/dns ratio of 1.42, whereas CL sequences had a ratio of 0.92. In contrast, the d s /d ns ratio for SNPs detected within tissue samples was 1.03. Overall, both swab and tissue samples showed no evidence of selective pressures (p >0.05).
Group 6 (Mass 3 +Ark) was the only group to contain a deletion. Of the 17 sequenced samples within the vaccine group (both tissue and swabs), 14 contained the same codon deletion (AAT) at position 1033-1035. This deletion removed a single amino acid (asparagine), and with no insertions, resulted in an overall smaller S1 protein.
Two isolates from Group 5 at 3 dpv contained a much higher SNP count of 27 and 30 (15 and 17 non-synonymous variations respectively). Furthermore, both isolates shared a high sequence similarity with each other, with only three nucleotide variations. However, when given in combination, only the 793B strains were identified at later time points (from 14 dpv), suggesting an increased ability for the 793B strains to replicate at a greater rate over the Mass strains within the same host. It was interesting to note that both 793B vaccine strains were detected at all sampling times throughout the experiment, As the hydrophobic properties of a peptide chain will affect the folding of the translated protein structure (Dill, 1990), we investigated hypothetical changes in hydrophobic properties arising from nucleotide (and subsequently amino acid) alterations in the partial S1
sequence. Since the spike glycoprotein is involved with host cell attachment and thought to be a causative reasoning behind strain variants (Jackwood et al., 2012) , it is possible that minor changes could affect the overall function, including the induction of neutralizing and haemagluttination inhibiting antibodies. Despite all hydrophobicity changes occurring between positions 293-334, those present in the Mass2 samples in Group 5 were at a separate location from the change in Mass 2 given alone (Group 2). As the only difference was the presence of a second strain at the time of inoculation, the additional vaccine strain (793B 2 ) may have influenced the mutation rate of the Mass 2 virus (Jia, et al., 1995; McKinley, et al., 2008) . As no Mass 2 hydrophobic changes persisted past 14 dpv, it appears that this could have provided some advantages for replication and persistence of this virus up to, but not beyond, 14 dpv.
The Sanger based sequencing approach utilised for this study generates sequence data based on the majority population within recovered isolates. As a result minor populations of either the same serotype, or different serotypes, would be neglected. During analysis minor peaks were only observed for a small number of recovered strains, however as the study included combined vaccine groups, a sequencing approach which takes this factor into consideration (such as next generation sequencing) may have identified the presence of other sub-populations.
Findings from this first comprehensive study on the effects of live IBV vaccine viruses, administered either singly or dually in day-old commercial broiler chicks, demonstrated that the majority of SNPs detected within recovered IBV vaccine strains lead to amino acid changes. Most such changes occur at an early stage of vaccination (less than 7 dpv), rather than at later ages. All detected hydrophobic changes occurred solely in OP and CL swabs. In IBV-vaccinated commercial broiler chicks with IBV maternal antibodies, it appears that the extent of part-S1 amino acid, and resulting hydrophobic changes, were limited.
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